XML 68 R10.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Cash Equivalents and Marketable Securities
12 Months Ended
Dec. 31, 2019
Investments, Debt and Equity Securities [Abstract]  
Cash Equivalents and Marketable Securities Cash Equivalents and Marketable Securities
At December 31, 2019, marketable securities consisted of the following (in thousands):
Amortized CostUnrealized GainsUnrealized LossesAggregate Fair Value
Money market funds$360,471  $—  $—  $360,471  
U.S. treasury debt securities10,342   (1) 10,349  
U.S. corporate debt securities95,706  164  (5) 95,865  
$466,519  $172  $(6) $466,685  
Included in cash and cash equivalents$360,471  $—  $—  $360,471  
Included in marketable securities$106,048  $172  $(6) $106,214  
At December 31, 2018, marketable securities consisted of the following (in thousands):
Amortized CostUnrealized GainsUnrealized LossesAggregate Fair Value
Money market funds$52,068  $—  $—  $52,068  
Commercial paper7,448  —  —  7,448  
U.S. treasury debt securities2,494  —  (1) 2,493  
U.S. corporate debt securities10,890  —  (67) 10,823  
$72,900  $—  $(68) $72,832  
Included in cash and cash equivalents$52,068  $—  $—  $52,068  
Included in marketable securities$20,832  $—  $(68) $20,764  
The following table presents gross unrealized losses and fair values for those marketable securities that were in an unrealized loss position as of December 31, 2019, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in thousands):
As of December 31, 2019
Less than 12 months12 months or greater
Fair ValueUnrealized LossFair ValueUnrealized Loss
U.S. treasury debt securities$2,020  $(1) $—  $—  
U.S. corporate debt securities7,065  (4) 2,000  (1) 
Total$9,085  $(5) $2,000  $(1) 
We do not believe any of the unrealized losses represented an other-than-temporary impairment based on our evaluation of available evidence, which includes our intent as of December 31, 2019 to hold these investments until the cost basis is recovered.